Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Austrian

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The New England Journal of Medicine|November 21, 1991
The protective efficacy of polyvalent pneumococcal polysaccharide vaccineE D Shapiro, A T Berg, R Austrian, et al.
Infection and Immunity|March 1, 1982
Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteersS C Szu, C J Lee, J C Parke, et al.
Journal of Clinical Microbiology|October 1, 1995
Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, BrazilM C Brandileone, V S Vieira, R C Zanella, et al.
The Journal of Infectious Diseases|December 1, 1983
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groupsJ B Robbins, R Austrian, C J Lee, et al.
The New England Journal of Medicine|October 5, 1978
Emergence of multiply resistant pneumococciM R Jacobs, H J Koornhof, R M Robins-Browne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Why have group A streptococci remained susceptible to penicillin? Report on a symposiumD L Horn, J B Zabriskie, R Austrian, et al.
The Pediatric Infectious Disease Journal|April 5, 2000
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center GroupS Black, H Shinefield, B Fireman, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The New England Journal of Medicine|November 21, 1991
The protective efficacy of polyvalent pneumococcal polysaccharide vaccineE D Shapiro, A T Berg, R Austrian, et al.
Infection and Immunity|March 1, 1982
Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteersS C Szu, C J Lee, J C Parke, et al.
Journal of Clinical Microbiology|October 1, 1995
Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, BrazilM C Brandileone, V S Vieira, R C Zanella, et al.
The Journal of Infectious Diseases|December 1, 1983
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groupsJ B Robbins, R Austrian, C J Lee, et al.
The New England Journal of Medicine|October 5, 1978
Emergence of multiply resistant pneumococciM R Jacobs, H J Koornhof, R M Robins-Browne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Why have group A streptococci remained susceptible to penicillin? Report on a symposiumD L Horn, J B Zabriskie, R Austrian, et al.
The Pediatric Infectious Disease Journal|April 5, 2000
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center GroupS Black, H Shinefield, B Fireman, et al.
Pageof 9